Report cover image

Nutritional Supplements Market

Publisher Grand View Research
Published Jan 20, 2026
Length 120 Pages
SKU # GV20873219

Description

Nutritional Supplements Market Summary

The global nutritional supplements market size was estimated at USD 517.09 billion in 2025 and is projected to reach USD 862.51 billion by 2033, growing at a CAGR of 6.62% from 2026 to 2033. Market growth is driven by rising health awareness, increasing demand for preventive healthcare, and growing adoption of functional foods and dietary supplements across all age groups.

Global Nutritional Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the nutritional supplements market on the basis of product, consumer group, formulation, sales channel, application, and region:
  • Product Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Sports Nutrition
  • Sports Supplements
  • Protein Supplements
  • Egg Protein
  • Soy Protein
  • Pea Protein
  • Lentil Protein
  • Hemp Protein
  • Casein
  • Quinoa Protein
  • Whey Protein
  • Whey Protein Isolate
  • Whey Protein Concentrate
  • Vitamins
  • Minerals
  • Calcium
  • Potassium
  • Magnesium
  • Iron
  • Zinc
  • Amino Acids
  • BCAA
  • Arginine
  • Aspartate
  • Glutamine
  • Beta Alanine
  • Creatine
  • L-carnitine
  • Probiotics
  • Omega-3 Fatty Acids
  • Carbohydrates
  • Maltodextrin
  • Dextrose
  • Waxy Maize
  • Karbolyn
  • Detox Supplements
  • Electrolytes
  • Others
  • Sports Drinks
  • Isotonic
  • Hypotonic
  • Hypertonic
  • Sports Foods
  • Protein Bars
  • Energy Bars
  • Protein Gel
  • Meal Replacement Products
  • Weight Loss Product
  • Fat Burners
  • Green Tea
  • Fiber
  • Protein
  • Green Coffee
  • Others
  • Dietary Supplements
  • Vitamins
  • Multivitamin
  • Vitamin A
  • Vitamin B
  • Vitamin C
  • Vitamin D
  • Vitamin E
  • Minerals
  • Enzymes
  • Amino Acids
  • Conjugated Linoleic Acids
  • Others
  • Functional Foods and Beverages
  • Probiotics
  • Omega-3
  • Others
  • Consumer Group Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Infants
  • Children
  • Adults
  • Age group 21 to 30
  • Age group 31 to 40
  • Age group 41 to 50
  • Age group 51 to 65
  • Pregnant
  • Geriatric
  • Formulation Outlook (Revenue, USD Million, 2021 - 2033)
  • Tablets
  • Capsules
  • Powder
  • Softgels
  • Liquid
  • Others
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Brick & Mortar
  • Direct Selling
  • Chemist/Pharmacies
  • Health Food Shops
  • Hyper Markets
  • Super Markets
  • E-commerce
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Sports & Athletics
  • General Health
  • Bone & Joint Health
  • Brain Health
  • Gastrointestinal Health
  • Immune Health
  • Cardiovascular Health
  • Skin/Hair/Nails
  • Sexual Health
  • Women’s Health
  • Anti-aging
  • Weight Management
  • Others
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Singapore
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Intervention
1.2.2. Distribution Method
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Complementary and Alternative Medicine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Complementary and Alternative Medicine Market: Intervention Business Analysis
4.1. Intervention Market Share, 2025 & 2033
4.2. Intervention Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Intervention, 2021 to 2033 (USD Million)
4.4. Traditional Alternative Medicine/Botanicals
4.4.1. Traditional Alternative Medicine/Botanicals Market, 2021 - 2033 (USD Million)
4.4.1.1. Ayurveda
4.4.1.1.1. Ayurveda Market, 2021 - 2033 (USD Million)
4.4.1.2. Apitherapy
4.4.1.2.1. Apitherapy Market, 2021 - 2033 (USD Million)
4.4.1.3. Bach Flower Therapy
4.4.1.3.1. Bach Flower Therapy Market, 2021 - 2033 (USD Million)
4.4.1.4. Naturopathic Medicine
4.4.1.4.1. Naturopathic Medicine Market, 2021 - 2033 (USD Million)
4.4.1.5. Traditional Chinese Medicine
4.4.1.5.1. Traditional Chinese Medicine Market, 2021 - 2033 (USD Million)
4.4.1.6. Traditional Korean Medicine
4.4.1.6.1. Traditional Korean Medicine Market, 2021 - 2033 (USD Million)
4.4.1.7. Traditional Japanese Medicine
4.4.1.7.1. Traditional Japanese Medicine Market, 2021 - 2033 (USD Million)
4.4.1.8. Traditional Mongolian Medicine
4.4.1.8.1. Traditional Mongolian Medicine Market, 2021 - 2033 (USD Million)
4.4.1.9. Traditional Tibetan Medicine
4.4.1.9.1. Traditional Tibetan Medicine Market, 2021 - 2033 (USD Million)
4.4.1.10. Zang Fu Theory
4.4.1.10.1. Zang Fu Theory Market, 2021 - 2033 (USD Million)
4.5. Mind Healing
4.5.1. Mind Healing Market, 2021 - 2033 (USD Million)
4.5.1.1. Autosuggestion
4.5.1.1.1. Ayurveda Market, 2021 - 2033 (USD Million)
4.5.1.2. Hypnotherapy
4.5.1.2.1. Hypnotherapy Market, 2021 - 2033 (USD Million)
4.5.1.3. Neuro-linguistic Programming
4.5.1.3.1. Neuro-linguistic Programming Market, 2021 - 2033 (USD Million)
4.5.1.4. Self-Hypnosis
4.5.1.4.1. Self- Hypnosis Market, 2021 - 2033 (USD Million)
4.5.1.5. Spiritual Mind Treatment
4.5.1.5.1. Spiritual Mind Treatment Market, 2021 - 2033 (USD Million)
4.5.1.6. Transcendental Meditation
4.5.1.6.1. Transcendental Market, 2021 - 2033 (USD Million)
4.6. Body Healing
4.6.1. Body Healing Market, 2021 - 2033 (USD Million)
4.6.1.1. Acupressure
4.6.1.1.1. Acupressure Market, 2021 - 2033 (USD Million)
4.6.1.2. Acupuncture
4.6.1.2.1. Acupuncture Market, 2021 - 2033 (USD Million)
4.6.1.3. Alexander Technique
4.6.1.3.1. Alexander Market, 2021 - 2033 (USD Million)
4.6.1.4. Auriculotherapy
4.6.1.4.1. Auriculotherapy Market, 2021 - 2033 (USD Million)
4.6.1.5. Autogenic Training
4.6.1.5.1. Autogenic Market, 2021 - 2033 (USD Million)
4.6.1.6. Chiropractic
4.6.1.6.1. Chiropractic Market, 2021 - 2033 (USD Million)
4.6.1.7. Cupping Therapy
4.6.1.7.1. Cupping Therapy Market, 2021 - 2033 (USD Million)
4.6.1.8. Kinesiology
4.6.1.8.1. Kinesiology Market, 2021 - 2033 (USD Million)
4.6.1.9. Osteomyology
4.6.1.9.1. Osteomyology Market, 2021 - 2033 (USD Million)
4.6.1.10. Pilates
4.6.1.10.1. Pilates Market, 2021 - 2033 (USD Million)
4.6.1.11. Qigong
4.6.1.11.1. Qigong Market, 2021 - 2033 (USD Million)
4.6.1.12. Reflexology
4.6.1.12.1. Reflexology Market, 2021 - 2033 (USD Million)
4.6.1.13. Yoga
4.6.1.13.1. Yoga Market, 2021 - 2033 (USD Million)
4.7. External Energy
4.7.1. External Energy Market, 2021 - 2033 (USD Million)
4.7.1.1. Magnetic Therapy
4.7.1.1.1. Magnetic Market, 2021 - 2033 (USD Million)
4.7.1.1.2. Bio-magnetic Therapy
4.7.1.1.2.1. Bio-magnetic Therapy Market, 2021 - 2033 (USD Million)
4.7.1.1.3. Magnetic Resonance Therapy
4.7.1.1.3.1. Magnetic Resonance Therapy Market, 2021 - 2033 (USD
4.7.1.2. Radionics
4.7.1.2.1. Radionics Market, 2021 - 2033 (USD Million)
4.7.1.3. Reiki
4.7.1.3.1. Reiki Market, 2021 - 2033 (USD Million)
4.7.1.4. Therapeutic Touch
4.7.1.4.1. Therapeutic Touch Market, 2021 - 2033 (USD Million)
4.7.1.5. Chakra Healing
4.7.1.5.1. Chakra Healing Market, 2021 - 2033 (USD Million)
4.8. Sensory Healing
4.8.1. Sensory Healing Market, 2021 - 2033 (USD Million)
4.9. Aromatherapy
4.9.1. Aromatherapy Market, 2021 - 2033 (USD Million)
4.10. Music Therapy
4.10.1. Music Therapy Market, 2021 - 2033 (USD Million)
4.11. Sonopuncture
4.11.1. Sonopuncture Market, 2021 - 2033 (USD Million)
4.12. Sound Therapy
4.12.1. Sound Therapy Market, 2021 - 2033 (USD Million)
Chapter 5. Complementary and Alternative Medicine Market: Distribution Method Business Analysis
5.1. Distribution Method Market Share, 2025 & 2033
5.2. Distribution Method Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Method, 2021 to 2033 (USD Million)
5.4. Direct Sales
5.4.1. Direct Sales Market, 2021 - 2033 (USD Million)
5.5. E-sales
5.5.1. E-sales Market, 2021 - 2033 (USD Million)
5.6. Distance Correspondence
5.6.1. Distance Correspondence Market, 2021 - 2033 (USD Million)
Chapter 6. Complementary and Alternative Medicine Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Complementary and Alternative Medicine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Type Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Type Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Type Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Type Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. UK Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Type Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Type Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Type Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Type Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Type Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Type Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Type Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Type Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Type Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Type Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Type Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Type Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Type Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Type Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Type Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Type Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Type Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Type Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Type Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Complementary and Alternative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Columbia Nutritional
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Nordic Nutraceuticals
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Ramamani Iyengar Memorial Yoga Institute
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. The Healing Company Ltd.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. John Schumacher Unity Woods Yoga Centre
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Sheng Chang Pharmaceutical Company
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Pure encapsulations, LLC.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Herb Pharm
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. AYUSH Ayurvedic Pte Ltd.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us